Logo image of EVMN

EVOMMUNE INC (EVMN) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:EVMN - US30054Y1073 - Common Stock

19.58 USD
+0.71 (+3.76%)
Last: 1/26/2026, 8:04:00 PM
20.06 USD
+0.48 (+2.45%)
Pre-Market: 1/27/2026, 8:17:47 AM
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to EVMN. EVMN was compared to 525 industry peers in the Biotechnology industry. While EVMN seems to be doing ok healthwise, there are quite some concerns on its profitability. EVMN is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • In the past year EVMN has reported negative net income.
  • EVMN had a negative operating cash flow in the past year.
EVMN Yearly Net Income VS EBIT VS OCF VS FCFEVMN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2023 2024 -20M -40M -60M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -71.00%, EVMN is doing worse than 63.43% of the companies in the same industry.
  • EVMN has a Return On Equity (-79.64%) which is in line with its industry peers.
Industry RankSector Rank
ROA -71%
ROE -79.64%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
EVMN Yearly ROA, ROE, ROICEVMN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2023 2024 -50 -100

1.3 Margins

  • EVMN does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
EVMN Yearly Profit, Operating, Gross MarginsEVMN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2023 2024 -200 -400 -600 -800 -1K

More info and screens

5

2. Health

2.1 Basic Checks

  • EVMN does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for EVMN remains at a similar level compared to 1 year ago.
  • The debt/assets ratio for EVMN is higher compared to a year ago.
EVMN Yearly Shares OutstandingEVMN Yearly Shares OutstandingYearly Shares Outstanding 2023 2024 10M 20M 30M
EVMN Yearly Total Debt VS Total AssetsEVMN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2023 2024 20M 40M 60M 80M

2.2 Solvency

  • An Altman-Z score of 29.96 indicates that EVMN is not in any danger for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 29.96, EVMN belongs to the top of the industry, outperforming 92.95% of the companies in the same industry.
  • A Debt/Equity ratio of 0.00 indicates that EVMN is not too dependend on debt financing.
  • EVMN's Debt to Equity ratio of 0.00 is in line compared to the rest of the industry. EVMN outperforms 47.62% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 29.96
ROIC/WACCN/A
WACC8.81%
EVMN Yearly LT Debt VS Equity VS FCFEVMN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2023 2024 0 20M -20M 40M -40M 60M

2.3 Liquidity

  • A Current Ratio of 9.40 indicates that EVMN has no problem at all paying its short term obligations.
  • The Current ratio of EVMN (9.40) is better than 79.62% of its industry peers.
  • EVMN has a Quick Ratio of 9.40. This indicates that EVMN is financially healthy and has no problem in meeting its short term obligations.
  • The Quick ratio of EVMN (9.40) is better than 79.81% of its industry peers.
Industry RankSector Rank
Current Ratio 9.4
Quick Ratio 9.4
EVMN Yearly Current Assets VS Current LiabilitesEVMN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2023 2024 20M 40M 60M 80M

More info and screens

1

3. Growth

3.1 Past

  • EVMN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -100.59%.
  • The Revenue has grown by 40.00% in the past year. This is a very strong growth!
EPS 1Y (TTM)-100.59%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%6.77%
Revenue 1Y (TTM)40%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-57.14%

3.2 Future

  • Based on estimates for the next years, EVMN will show a very negative growth in Earnings Per Share. The EPS will decrease by -11.87% on average per year.
  • EVMN is expected to show a very negative growth in Revenue. In the coming years, the Revenue will decrease by -25.99% yearly.
EPS Next Y-87.28%
EPS Next 2Y-12.44%
EPS Next 3Y-11.87%
EPS Next 5YN/A
Revenue Next Year89.43%
Revenue Next 2Y-41.42%
Revenue Next 3Y-25.99%
Revenue Next 5YN/A

3.3 Evolution

EVMN Yearly Revenue VS EstimatesEVMN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 2M 4M 6M 8M 10M
EVMN Yearly EPS VS EstimatesEVMN Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 -1 -2 -3 -4

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for EVMN. In the last year negative earnings were reported.
  • Also next year EVMN is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
EVMN Price Earnings VS Forward Price EarningsEVMN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
EVMN Per share dataEVMN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2

4.3 Compensation for Growth

  • A cheap valuation may be justified as EVMN's earnings are expected to decrease with -11.87% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-12.44%
EPS Next 3Y-11.87%

More info and screens

0

5. Dividend

5.1 Amount

  • EVMN does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

EVOMMUNE INC / EVMN FAQ

Can you provide the ChartMill fundamental rating for EVOMMUNE INC?

ChartMill assigns a fundamental rating of 2 / 10 to EVMN.


What is the valuation status of EVOMMUNE INC (EVMN) stock?

ChartMill assigns a valuation rating of 0 / 10 to EVOMMUNE INC (EVMN). This can be considered as Overvalued.


What is the profitability of EVMN stock?

EVOMMUNE INC (EVMN) has a profitability rating of 0 / 10.